{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:01:34Z","timestamp":1783353694645,"version":"3.54.6"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072726"],"award-info":[{"award-number":["82072726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117367","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:22:54Z","timestamp":1758900174000},"page":"117367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P3","title":["Dual activation of PPAR\u03b1\/\u03b3 by bezafibrate triggers PINK1\/Parkin-Mediated mitophagy to enhance lenvatinib sensitivity in hepatocellular carcinoma"],"prefix":"10.1016","volume":"242","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuteng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-2050","authenticated-orcid":false,"given":"Tianxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2025.117367_b0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-024-01647-1","article-title":"lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2025.117367_b0010","doi-asserted-by":"crossref","unstructured":"Eun JW, Yoon JH, Ahn HR, Kim S, Kim YB, Lim SB, Park W, Kang TW, Baek GO, Yoon MG, Son JA, Weon JH, Kim SS, Cho HJ, Cheong JY. Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Commun (Lond). 2023 Apr;43(4):455-479. doi: 10.1002\/cac2.12414. Epub 2023 Mar 14. PMID: 36919193; PMCID: PMC10091107.","DOI":"10.1002\/cac2.12414"},{"issue":"15","key":"10.1016\/j.bcp.2025.117367_b0015","article-title":"Single-cell mitophagy patterns within the tumor microenvironment modulate intercellular communication, impacting the progression and prognosis of hepatocellular carcinoma","volume":"6","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117367_b0020","doi-asserted-by":"crossref","unstructured":"Song C, Pan S, Zhang J, Li N, Geng Q. Mitophagy: A novel perspective for insighting into cancer and cancer treatment. Cell Prolif. 2022 Dec;55(12):e13327. doi: 10.1111\/cpr.13327. Epub 2022 Oct 5. PMID: 36200262; PMCID: PMC9715364.","DOI":"10.1111\/cpr.13327"},{"issue":"1","key":"10.1016\/j.bcp.2025.117367_b0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2025.117367_b0030","article-title":"Mitochondrial dysfunction: a promising therapeutic target for liver diseases","volume":"11","author":"Chen","year":"2023","journal-title":"Genes Dis."},{"issue":"5","key":"10.1016\/j.bcp.2025.117367_b0035","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.7150\/ijbs.107195","article-title":"Regulated Cell Death in lenvatinib Resistance of Hepatocellular Carcinoma: from Molecular Mechanisms to Therapeutic strategies","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117367_b0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41419-024-06870-9","article-title":"BNIP3-mediated mitophagy boosts the competitive growth of lenvatinib-resistant cells via energy metabolism reprogramming in HCC","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117367_b0045","doi-asserted-by":"crossref","unstructured":"Yao J, Wang J, Xu Y, Guo Q, Sun Y, Liu J, Li S, Guo Y, Wei L. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy. 2022 Aug;18(8):1879-1897. doi: 10.1080\/15548627.2021.2007027. Epub 2021 Dec 10. PMID: 34890308; PMCID: PMC9450969.","DOI":"10.1080\/15548627.2021.2007027"},{"key":"10.1016\/j.bcp.2025.117367_b0050","doi-asserted-by":"crossref","unstructured":"Sheard JJ, Southam AD, MacKay HL, Ellington MA, Snow MD, Khanim FL, Bunce CM, Johnson WE. Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells. Biosci Rep. 2021 Jan 29;41(1):BSR20202505. doi: 10.1042\/BSR20202505. PMID: 33289496; PMCID: PMC7786328.","DOI":"10.1042\/BSR20202505"},{"issue":"16","key":"10.1016\/j.bcp.2025.117367_b0055","article-title":"bezafibrate-driven mitochondrial targeting enhances antitumor immunity and prevents lung cancer via CD8+ T cell infiltration and MDSC reduction","volume":"15","author":"Pan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117367_b0060","doi-asserted-by":"crossref","unstructured":"Augustyniak J, Lenart J, Gaj P, Kolanowska M, Jazdzewski K, Stepien PP, Buzanska L. bezafibrate Upregulates Mitochondrial Biogenesis and Influence Neural Differentiation of Human-Induced Pluripotent Stem Cells. Mol Neurobiol. 2019 Jun;56(6):4346-4363. doi: 10.1007\/s12035-018-1368-2. Epub 2018 Oct 13. PMID: 30315479; PMCID: PMC6505510.","DOI":"10.1007\/s12035-018-1368-2"},{"key":"10.1016\/j.bcp.2025.117367_b0065","article-title":"Dec 20","author":"Noe","year":"2012","journal-title":"Retraction. in"},{"issue":"1","key":"10.1016\/j.bcp.2025.117367_b0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/hmg\/ddy343","article-title":"bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia","volume":"28","author":"Waskowicz","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.bcp.2025.117367_b0075","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.3390\/ijms23094726","article-title":"Functional and Structural Insights into Human PPAR\u03b1\/\u03b4\/\u03b3 Subtype Selectivity of bezafibrate, Fenofibric Acid, and Pemafibrate","volume":"23","author":"Honda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117367_b0080","doi-asserted-by":"crossref","unstructured":"Augustyniak J, Lenart J, Gaj P, Kolanowska M, Jazdzewski K, Stepien PP, Buzanska L. bezafibrate Upregulates Mitochondrial Biogenesis and Influence Neural Differentiation of Human-Induced Pluripotent Stem Cells. Mol Neurobiol. 2019 Jun;56(6):4346-4363. doi: 10.1007\/s12035-018-1368-2. Epub 2018 Oct 13. PMID: 30315479; PMCID: PMC6505510.","DOI":"10.1007\/s12035-018-1368-2"},{"key":"10.1016\/j.bcp.2025.117367_b0085","doi-asserted-by":"crossref","unstructured":"Steele H, Gomez-Duran A, Pyle A, Hopton S, Newman J, Stefanetti RJ, Charman SJ, Parikh JD, He L, Viscomi C, Jakovljevic DG, Hollingsworth KG, Robinson AJ, Taylor RW, Bottolo L, Horvath R, Chinnery PF. Metabolic effects of bezafibrate in mitochondrial disease. EMBO Mol Med. 2020 Mar 6;12(3):e11589. doi: 10.15252\/emmm.201911589. Epub 2020 Feb 28. PMID: 32107855; PMCID: PMC7059007.","DOI":"10.15252\/emmm.201911589"},{"issue":"1","key":"10.1016\/j.bcp.2025.117367_b0090","first-page":"e0612","article-title":"PPAR agonists for the treatment of cholestatic liver diseases: over a decade of clinical progress","volume":"9","author":"Hayes","year":"2024","journal-title":"Hepatol Commun."},{"issue":"2","key":"10.1016\/j.bcp.2025.117367_b0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/ijms26020736","article-title":"Discovery of PPAR Alpha Lipid Pathway Modulators that do not Bind Directly to the Receptor as potential Anti-Cancer Compounds","volume":"26","author":"Al Subait","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.bcp.2025.117367_b0100","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.3390\/ijms252111760","article-title":"Role of Peroxisome Proliferator-Activated Receptor \u03b1-Dependent Mitochondrial Metabolism in Ovarian Cancer Stem Cells","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117367_b0105","doi-asserted-by":"crossref","unstructured":"Cetti F, Ossoli A, Garavaglia C, Da Dalt L, Norata GD, Gomaraschi M. PPAR-mediated reduction of lipid accumulation in hepatocytes involves the autophagy-lysosome-mitochondrion axis. Ann Med. 2025 Dec;57(1):2497112. doi: 10.1080\/07853890.2025.2497112. Epub 2025 Apr 28. PMID: 40289698; PMCID: PMC12039397.","DOI":"10.1080\/07853890.2025.2497112"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500632X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500632X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T22:38:30Z","timestamp":1761777510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500632X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":21,"alternative-id":["S000629522500632X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117367","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual activation of PPAR\u03b1\/\u03b3 by bezafibrate triggers PINK1\/Parkin-Mediated mitophagy to enhance lenvatinib sensitivity in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117367"}}